Bristol Myers Squibb Co
said on Monday that its blockbuster cancer immunotherapy
Opdivo performed well in two separate late-stage trials,
prolonging survival in…
Two big drugmakers. One clear winner for investors....…
Top Research Reports for Comcast, Bristol-Myers & Walgreens...…
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…
The program will evaluate the safety and efficacy of Intensitys lead product INT230-6, an investigational, novel and potent anti-cancer drug…
Few stocks have avoided the mass coronavirus sell-offs, and Bristol Myers is no exception. Is this cheap stock worth a…
In the latest trading session, Bristol-Myers Squibb (BMY) closed at $60.02, marking a +1.87% move from the previous day....…
A federal judge increased to $1.2
billion the damages that Gilead Sciences Inc must pay
to Bristol-Myers Squibb Co in a patent…
Um den gesamten Artikel unter trib.al zu lesen, klicken Sie bitte auf die Überschrift...…
Bristol-Myers (BMY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the companys earnings prospects. This…
Bristol Myers (BMY) applications for Opdivo in combination with Yervoy administered concomitantly with a limited course of chemotherapy have been…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Todays Daily Dose brings you news about Bristol Myers regulatory catalyst; Liquidias pulmonary arterial hypertension drug candidate; Moleculin Biotech joining…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Bristol-Myers Squibb (BMY) closed the most recent trading day at $56.80, moving -1.85% from the previous trading session....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Bristol Myers (BMY) and Acceleron received FDA nod for the label expansion of Reblozyl for MDS patients who require RBC…
Reblozyl recently became the first treatment for adults with lower-risk myelodysplastic syndromes....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Myelodysplastic syndromes are a group of closely related blood cancers characterised by ineffective production of healthy red blood cells, white…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
NEW YORK , April 3, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BMY,…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
FOLGENDE WERTPAPIERE WERDEN AM 02.04.2020 EX DIVIDENDE/ZINSEN GEHANDELT.
THE EX-DIVIDEND/INTEREST DAY OF THE FOLLOWING SHARES WILL BE 02.04.2020.
INSTR EXCH…
Bristol-Myers Squibb (BMY) closed the most recent trading day at $54.86, moving -1.58% from the previous trading session....…
Bristol Myers (BMY) and bluebird file a biologics license application to the FDA seeking approval of idecabtagene vicleucel for heavily…
IONpath, Inc.: Menlo Park, Kalifornien (ots/PRNewswire) - IONpath, Inc. gab heute bekannt, dass gemeinsam mit Bristol Myers Squibb ein Artikel…
The submission is based on results from the pivotal Phase 2 KarMMa study. The KarMMa study evaluated the efficacy and…
FOLGENDE WERTPAPIERE WERDEN AM 01.04.2020 CUM DIVIDENDE/ZINSEN UND AM 02.04.2020 EX DIVIDENDE/ZINSEN GEHANDELT.
THE PRE-DIVIDEND/INTEREST DAY OF THE FOLLOWING SHARES WILL…
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
The pharma giant has been tossed into the discount bin, but thats not the only reason to consider buying its…
Bristol-Myers Squibbs (NYSE: BMY) cardiovascular drug sales have surged 326% from $1.9 billion in 2015 to $7.9 billion in 2019,…
ZEPOSIA, an oral medication taken once daily, is the only approved sphingosine-1-phosphate (S1P) receptor modulator that offers RMS patients an…
Novartis, Boehringer Ingelheim, Bristol-Myers Squibb, Eisai, Eli Lilly, Gilead, GSK, Johnson & Johnson, Merck, Pfizer, Sanofi, BD and bioMérieux are…
Todays Daily Dose brings you news about BioSig Technologies foray into COVID-19 drug development, FDA approval of Bristol-Myers multiple sclerosis…
Bristol-Myers Squibb Company (NYSE: BMY) shares are trading higher after the company announced the FDA has approved ZEPOSIA, its new…
Zacks.com featured highlights include: Bristol-Myers Squibb, AmerisourceBergen, Leidos, Xcel Energy and Caseys General Stores...…
But the big drugmaker will delay its commercial launch due to the COVID-19 pandemic....…
Bristol-Myers Squibb Co said on
Thursday the U.S. Food and Drug Administration approved its
multiple sclerosis (MS) treatment, Zeposia, but the launch…
Heres a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit…
The U.S. Food and Drug Administration
on Thursday approved Bristol-Myers Squibb Cos multiple
sclerosis (MS) treatment, Zeposia, but its launch will be
delayed…
Shares of Bristol-Myers Squibb Co. gained 1% in premarket trading on Thursday after the drugmaker said the Food and…
The U.S. Food and Drug Administration
on Thursday approved Bristol-Myers Squibb Cos multiple
sclerosis (MS) treatment, Zeposia, but its launch will be
delayed…
The U.S. Food and Drug Administration
on Thursday approved Bristol-Myers Squibb Cos multiple
sclerosis (MS) treatment, Zeposia, one of the key treatments
behind…
Bristol-Myers Squibb (NYSE: BMY) could see a 40% upside from the current levels, per our price estimate of $68, which…
- Celgene Declines to Exercise Opt-in Right for MAT2A Inhibitor AG-270 -...…
Sales of Bristol-Myers Squibb Cos cancer drug Abraxane have been suspended in China based on findings at a third-party manufacturing…
Sales of Bristol-Myers Squibb Cos
cancer drug Abraxane have been suspended in China based
on findings at a third-party manufacturing plant in…
China has suspended sale, import and
use of Bristol-Myers Squibb Cos cancer drug, Abraxane,
the U.S. drugmakers China marketing partner said on…